Postnatal antibiotic exposure due to maternal group B streptococcus is associated with childhood asthma
Pediatric Allergy and Immunology · 2025
DOI: 10.1111/pai.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2025. Verfasst von Eyal Kristal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Saban children's Hospital, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel. Hauptthemen laut MEDLINE: Asthma, Anti-Bacterial Agents, Streptococcal Infections, Streptococcus agalactiae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Previous studies identified early‐life antibiotic exposure as a risk factor for childhood asthma. However, this association may be confounded by an indication, as antibiotics are often prescribed for respiratory infections, which themselves promote asthma. To mitigate this bias, we aim to assess the unique contribution of postnatal antibiotic therapy, given to non‐infected infants for maternal indication, on childhood asthma risk.
Methods
We screened electronic medical records to identify healthy full‐term infants born during 2006–2018 to mothers with a positive group B streptococcus (GBS) vaginal culture. Infants with postnatal respiratory symptoms/pneumonia or positive blood/cerebrospinal fluid cultures were excluded. The primary outcome was an asthma diagnosis by age 6 years. We fitted a multivariable quasi‐Poisson regression model to assess the unique contribution of antibiotic treatment to asthma diagnosis. As a validation step, we utilized a propensity model in which infants treated with antibiotics were matched 1:3 with infants not treated.
Results
The cohort included 14,807 infants, of whom 311 received antibiotics. After controlling for potential confounders, postnatal antibiotic exposure was associated with higher asthma risk (adjusted risk ratio [aRR] = 1.3, 95%; confidence interval [CI] 1.04–1.61, p = .017). Higher asthma risk was validated in the propensity model (aRR = 1.49, 95% CI 1.12–1.96 p = .005). Postnatal antibiotic therapy was also associated with secondary outcomes such as the short‐acting beta‐ag use (aRR = 1.13, 95% CI 0.99–1.28, p = .072) and allergic rhinitis diagnosis (aRR = 3.00, 95% CI 1.43–6.30, p = .003).
Conclusions
Postnatal antibiotic therapy administrated for maternal GBS, not confounded by infants' infections, was associated with higher childhood asthma risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saban children's Hospital, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
- The Kipper Institute of Allergy and Immunology. Schneider Children's Medical Center of Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Research and Innovation Center, Saban Children's Hospital, Soroka University Medical Center, Be'er Sheva, Israel.
ORCID-Profile: Eyal Kristal, Yoram Faitelson
Zitieren
APA
Kristal, E., Shitrit, I. B., Faitelson, Y., Hazan, G., & Beigelman, A. (2025). Postnatal antibiotic exposure due to maternal group B streptococcus is associated with childhood asthma. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70167
Vancouver
Kristal E, Shitrit IB, Faitelson Y, Hazan G, Beigelman A. Postnatal antibiotic exposure due to maternal group B streptococcus is associated with childhood asthma. Pediatric Allergy and Immunology. 2025. doi:10.1111/pai.70167
BibTeX
@article{Kristal2025,
author = {Kristal, Eyal and Shitrit, Itamar Ben and Faitelson, Yoram and Hazan, Guy and Beigelman, Avraham},
title = {Postnatal antibiotic exposure due to maternal group B streptococcus is associated with childhood asthma},
journal = {Pediatric Allergy and Immunology},
year = {2025},
doi = {10.1111/pai.70167}
}
EUVIMED